You are here

Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme

Phase 1 trial underway at the University of Alabama at Birmingham in recurrent glioblastoma multiforme
Wednesday, February 20, 2019 - 08:30